Gonadotrophin receptor hormone analogues in combination with add-back therapy: an update
Menopause International, 05/30/2012
McLaren JS et al. – This efficacy does not come without a cost and the side–effects of the hypo–estrogenic state have limited their application. The use of add–back therapy to counter these effects has enabled wider application, longer durations of treatment and an increase in compliance. This review article is an update on the evidence supporting gonadotrophin receptor hormone analogues in combination with add–back therapy.